|
Catalyst Pharmaceuticals, Inc. (CPRX) DCF Valuation
US | Healthcare | Biotechnology | NASDAQ
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Catalyst Pharmaceuticals, Inc. (CPRX) Bundle
Simplify Catalyst Pharmaceuticals, Inc. (CPRX) valuation with this customizable DCF Calculator! Featuring real Catalyst Pharmaceuticals, Inc. (CPRX) financials and adjustable forecast inputs, you can test scenarios and uncover Catalyst Pharmaceuticals, Inc. (CPRX) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 119.1 | 140.8 | 214.2 | 398.2 | 491.7 | 712.7 | 1,033.0 | 1,497.3 | 2,170.1 | 3,145.4 |
| Revenue Growth, % | 0 | 18.27 | 52.1 | 85.9 | 23.49 | 44.94 | 44.94 | 44.94 | 44.94 | 44.94 |
| EBITDA | 41.3 | 52.4 | 101.8 | 119.7 | 195.1 | 269.6 | 390.8 | 566.5 | 821.0 | 1,190.0 |
| EBITDA, % | 34.69 | 37.2 | 47.54 | 30.06 | 39.68 | 37.83 | 37.83 | 37.83 | 37.83 | 37.83 |
| Depreciation | .9 | .5 | 1.5 | 32.9 | .0 | 14.3 | 20.7 | 30.1 | 43.6 | 63.1 |
| Depreciation, % | 0.74351 | 0.34367 | 0.69373 | 8.26 | 0 | 2.01 | 2.01 | 2.01 | 2.01 | 2.01 |
| EBIT | 40.4 | 51.9 | 100.4 | 86.8 | 195.1 | 255.3 | 370.1 | 536.4 | 777.5 | 1,126.8 |
| EBIT, % | 33.94 | 36.85 | 46.85 | 21.8 | 39.68 | 35.83 | 35.83 | 35.83 | 35.83 | 35.83 |
| Total Cash | 140.3 | 191.3 | 298.4 | 137.6 | 517.6 | 619.4 | 897.8 | 1,301.3 | 1,886.1 | 2,733.7 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 6.0 | 6.6 | 10.4 | 53.5 | 65.5 | 59.0 | 85.4 | 123.8 | 179.5 | 260.2 |
| Account Receivables, % | 5.03 | 4.7 | 4.87 | 13.44 | 13.32 | 8.27 | 8.27 | 8.27 | 8.27 | 8.27 |
| Inventories | 4.7 | 7.9 | 6.8 | 15.6 | 19.5 | 29.3 | 42.5 | 61.6 | 89.3 | 129.4 |
| Inventories, % | 3.91 | 5.59 | 3.18 | 3.93 | 3.97 | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 |
| Accounts Payable | 4.3 | 2.8 | 4.0 | 14.8 | 16.6 | 20.6 | 29.9 | 43.4 | 62.9 | 91.1 |
| Accounts Payable, % | 3.57 | 1.97 | 1.86 | 3.72 | 3.37 | 2.9 | 2.9 | 2.9 | 2.9 | 2.9 |
| Capital Expenditure | .0 | -1.0 | .0 | -198.5 | -.2 | -72.2 | -104.6 | -151.7 | -219.8 | -318.6 |
| Capital Expenditure, % | -0.0095723 | -0.72497 | -0.01353856 | -49.85 | -0.04697662 | -10.13 | -10.13 | -10.13 | -10.13 | -10.13 |
| Tax Rate, % | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 | 24.22 |
| EBITAT | 72.3 | 38.9 | 79.6 | 65.6 | 147.9 | 207.1 | 300.2 | 435.2 | 630.7 | 914.2 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | 66.8 | 33.0 | 79.5 | -141.1 | 133.6 | 150.1 | 185.9 | 269.5 | 390.6 | 566.2 |
| WACC, % | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 | 7.78 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 1,193.2 | |||||||||
| Long Term Growth Rate, % | 3.00 | |||||||||
| Free cash flow (T + 1) | 583 | |||||||||
| Terminal Value | 12,193 | |||||||||
| Present Terminal Value | 8,382 | |||||||||
| Enterprise Value | 9,575 | |||||||||
| Net Debt | -515 | |||||||||
| Equity Value | 10,090 | |||||||||
| Diluted Shares Outstanding, MM | 125 | |||||||||
| Equity Value Per Share | 80.76 |
What You Will Get
- Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to generate various scenarios.
- Real-World Data: Catalyst Pharmaceuticals, Inc.’s (CPRX) financial data pre-filled to kickstart your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A sleek Excel model that adjusts to your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and saving time.
Key Features
- Comprehensive CPRX Data: Pre-filled with Catalyst Pharmaceuticals' historical financials and future projections.
- Fully Customizable Inputs: Modify revenue growth, profit margins, WACC, tax rates, and capital expenditures.
- Dynamic Valuation Model: Automatic recalculations of Net Present Value (NPV) and intrinsic value based on your adjustments.
- Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- User-Friendly Interface: Intuitive, organized, and suitable for both professionals and newcomers.
How It Works
- Download: Obtain the pre-built Excel file featuring Catalyst Pharmaceuticals, Inc.'s (CPRX) financial data.
- Customize: Modify forecasts, including revenue growth, EBITDA %, and WACC as needed.
- Update Automatically: Real-time updates for intrinsic value and NPV calculations as you make changes.
- Test Scenarios: Develop various projections and instantly compare the results.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose This Calculator for Catalyst Pharmaceuticals, Inc. (CPRX)?
- Accuracy: Utilizes real Catalyst Pharmaceuticals financial data for precise calculations.
- Flexibility: Allows users to easily test and adjust inputs to fit their needs.
- Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
- Professional-Grade: Crafted with the precision and usability expected by CFOs.
- User-Friendly: Designed for ease of use, suitable for individuals without extensive financial modeling skills.
Who Should Use This Product?
- Investors: Accurately assess Catalyst Pharmaceuticals’ fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Catalyst Pharmaceuticals (CPRX).
- Consultants: Easily customize the template for valuation reports for clients in the pharmaceutical sector.
- Entrepreneurs: Acquire insights into financial modeling practices employed by leading pharmaceutical companies.
- Educators: Employ it as a teaching resource to illustrate valuation methodologies in the biotech industry.
What the Template Contains
- Comprehensive DCF Model: Editable template with detailed valuation calculations tailored for Catalyst Pharmaceuticals, Inc. (CPRX).
- Real-World Data: Catalyst Pharmaceuticals' historical and projected financials preloaded for thorough analysis.
- Customizable Parameters: Adjust WACC, growth rates, and tax assumptions to explore various scenarios.
- Financial Statements: Complete annual and quarterly breakdowns for enhanced insights into performance.
- Key Ratios: Integrated analysis for profitability, efficiency, and leverage specific to Catalyst Pharmaceuticals.
- Dashboard with Visual Outputs: Charts and tables designed for clear, actionable results related to Catalyst Pharmaceuticals, Inc. (CPRX).
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.